$41.75
-0.09[-0.22%]
Last update: 9:30AM Get Real Time Here
Ionis Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ionis Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | IONS | Q1 | -$0.68 | -$1.03 | — | — | $131.00M | $144.06M | — | — | Get Alert |
02/21/2024 | AM | IONS | Q4 | -$1.18 | -$0.83 | -$0.06 | 92.77% | $152.00M | $174.76M | $325.00M | 85.97% | Get Alert |
11/02/2023 | AM | IONS | Q3 | -$0.16 | -$1.07 | -$0.85 | 20.56% | $160.00M | $132.90M | $144.00M | 8.35% | Get Alert |
08/09/2023 | AM | IONS | Q2 | -$0.56 | -$0.90 | -$0.41 | 54.44% | $134.00M | $138.83M | $188.00M | 35.42% | Get Alert |
05/03/2023 | AM | IONS | Q1 | -$0.27 | -$0.91 | -$0.68 | 25.27% | $142.00M | $128.12M | $131.00M | 2.25% | Get Alert |
02/22/2023 | AM | IONS | Q4 | $1.55 | -$0.92 | -$1.18 | -28.26% | $440.00M | $158.65M | $152.00M | -4.19% | Get Alert |
11/09/2022 | AM | IONS | Q3 | -$0.34 | -$0.74 | -$0.16 | 78.38% | $133.00M | $143.84M | $160.00M | 11.23% | Get Alert |
08/09/2022 | AM | IONS | Q2 | -$0.26 | -$0.62 | -$0.56 | 9.68% | $126.00M | $140.70M | $134.00M | -4.76% | Get Alert |
05/04/2022 | AM | IONS | Q1 | -$0.32 | -$0.71 | -$0.27 | 61.97% | $112.00M | $125.21M | $142.00M | 13.41% | Get Alert |
02/24/2022 | AM | IONS | Q4 | $0.81 | $0.28 | $1.55 | 453.57% | $290.00M | $259.15M | $440.00M | 69.79% | Get Alert |
11/03/2021 | AM | IONS | Q3 | -$0.22 | -$0.51 | -$0.34 | 33.33% | $160.00M | $158.38M | $133.00M | -16.02% | Get Alert |
08/04/2021 | AM | IONS | Q2 | -$0.23 | -$0.58 | -$0.26 | 55.17% | $146.00M | $129.94M | $126.00M | -3.03% | Get Alert |
05/05/2021 | AM | IONS | Q1 | -$0.35 | -$0.53 | -$0.32 | 39.62% | $133.00M | — | $112.00M | — | Get Alert |
02/24/2021 | AM | IONS | Q4 | $1.33 | $0.28 | $0.81 | 189.29% | $494.00M | $274.48M | $290.00M | 5.65% | Get Alert |
11/04/2020 | AM | IONS | Q3 | $0.18 | -$0.09 | -$0.22 | -144.44% | $168.00M | $182.14M | $160.00M | -12.16% | Get Alert |
08/05/2020 | AM | IONS | Q2 | -$0.01 | -$0.27 | -$0.23 | 14.81% | $164.00M | $148.87M | $146.00M | -1.93% | Get Alert |
05/06/2020 | AM | IONS | Q1 | $0.62 | -$0.12 | -$0.35 | -191.67% | $297.00M | $161.42M | $133.00M | -17.61% | Get Alert |
02/26/2020 | AM | IONS | Q4 | $0.19 | $0.93 | $1.33 | 43.01% | $192.11M | $409.28M | $494.00M | 20.70% | Get Alert |
11/06/2019 | AM | IONS | Q3 | -$0.03 | -$0.33 | $0.18 | 154.55% | $145.40M | $153.37M | $168.00M | 9.54% | Get Alert |
Ionis Pharmaceuticals (IONS) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 21, 2024 for Q4.
The Actual EPS was $-0.06, which beat the estimate of $-0.83.
The Actual Revenue was $325M, which beat the estimate of $174.8M.
Browse earnings estimates, EPS, and revenue on all stocks.